Scholarlink

<p>Nitrogen-containing heterocycles remain central to drug discovery, with imidazole standing out for its versatility and biological relevance. Sulfur substitution yields thioimidazoles, which offer altered electronic properties and pharmacokinetics. In parallel, the 3,4,5-trimethoxyphenyl (TMP) group is recognized as a privileged pharmacophore in oncology, anchoring ligands within protein binding pockets and contributing to multi-target activity. Here, we combined these motifs to synthesize a series of thioimidazole–TMP conjugates. Their activity was tested across human cancer cell models representing distinct tissue origins, alongside non-malignant lung fibroblasts. Among the library, compound <b>13b</b> emerged as a lead, showing sub-micromolar potency in the most sensitive cancer cells while remaining inactive in fibroblasts, yielding a selectivity index above 20. Mechanistic studies demonstrated that <b>13b</b> induces a canonical apoptotic program: Annexin V positivity, caspase-3/7 activation, and γH2AX foci consistent with DNA damage. Crucially, these effects extended beyond two-dimensional assays. In three-dimensional spheroid models, which better mimic tumor architecture, <b>13b</b> penetrated compact structures, suppressed growth, and induced apoptosis in a concentration-dependent manner. Together, these findings indicate that merging thioimidazole and TMP frameworks yields a hybrid scaffold with strong promise in anticancer research. Compound <b>13b</b> therefore represents a promising candidate for further mechanistic investigation and optimization toward improved drug-like properties.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Synthesis and anticancer evaluation of novel thioimidazole derivatives bearing a trimethoxyphenyl moiety

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月27日

查看全文
  • Natalia Maciejewska,
  • Birutė Grybaitė,
  • Kazimieras Anusevičius,
  • Vytautas Mickevičius

摘要

Nitrogen-containing heterocycles remain central to drug discovery, with imidazole standing out for its versatility and biological relevance. Sulfur substitution yields thioimidazoles, which offer altered electronic properties and pharmacokinetics. In parallel, the 3,4,5-trimethoxyphenyl (TMP) group is recognized as a privileged pharmacophore in oncology, anchoring ligands within protein binding pockets and contributing to multi-target activity. Here, we combined these motifs to synthesize a series of thioimidazole–TMP conjugates. Their activity was tested across human cancer cell models representing distinct tissue origins, alongside non-malignant lung fibroblasts. Among the library, compound 13b emerged as a lead, showing sub-micromolar potency in the most sensitive cancer cells while remaining inactive in fibroblasts, yielding a selectivity index above 20. Mechanistic studies demonstrated that 13b induces a canonical apoptotic program: Annexin V positivity, caspase-3/7 activation, and γH2AX foci consistent with DNA damage. Crucially, these effects extended beyond two-dimensional assays. In three-dimensional spheroid models, which better mimic tumor architecture, 13b penetrated compact structures, suppressed growth, and induced apoptosis in a concentration-dependent manner. Together, these findings indicate that merging thioimidazole and TMP frameworks yields a hybrid scaffold with strong promise in anticancer research. Compound 13b therefore represents a promising candidate for further mechanistic investigation and optimization toward improved drug-like properties.